🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate GSK Biologicals' DTPa-HBV-IPV/Hib vaccine given as...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-09-23
Trial ID
NCT00753649
Treatments Being Tested
This study will assess the immunogenicity and safety of GlaxoSmithKline (GS...
Status
Completed
Location
Multiple Locations
Start Date
1999-01
Trial ID
NCT01457508
Treatments Being Tested
This study aims to evaluate the persistence of anti-poliovirus antibodies i...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-04-25
Trial ID
NCT01323647
Treatments Being Tested
This study evaluates the immunogenicity and safety of Infanrix hexa™ (DTPa-...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-04-16
Trial ID
NCT01353703
Treatments Being Tested
This study will evaluate the persistence of immunity to hepatitis B 10 to 1...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-06-07
Trial ID
NCT01138098
Treatments Being Tested
The purpose of this study is to evaluate the long-term antibody persistence...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-05-16
Trial ID
NCT00454987
Treatments Being Tested
This is a follow-up of the primary series vaccination schedule in Study A3L...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01444781
The aim of this study is to assess antibody persistence in infants who rece...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-05-30
Trial ID
NCT01358825
Treatments Being Tested
The purpose of this trial is to clinically confirm that the manufacturing p...
Status
Completed
Location
Multiple Locations
Start Date
2006-11
Trial ID
NCT00404651
The purpose of this study is to evaluate safety and immunogenicity of Pedia...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00343421
Treatments Being Tested